MAPK7 and breast carcinoma: This alternate pathway is not observed in MDA-MB-231 cells upon ERK5 gene silencing (Figure 8c), perhaps revealing a vulnerability of breast cancer cells that may depend upon Brk/ERK5 complexes for their increased mobility.